The news is by your side.

cancer immunotherapy

More than 2,000 drugs now in cancer immunotherapy race

LONDON: The race to develop new immunotherapy treatments against cancer has sparked an unprecedented explosion in the oncology drug pipeline, with more than 2,000 immune system-boosting agents now in development. The result is a scramble for patients to enrol in clinical trials, duplication of effort and the likely ultimate failure of many projects, according to experts. Aiman Shalabi of the non-profit Cancer Research Institute said on Thursday that a global analysis, the first of its kind, had found 940 immunotherapy…